March 16, 2004Circulation1,219 citations
View Full PaperTargeted Anticytokine Therapy in Patients With Chronic Heart Failure
Structured PICO
Does etanercept reduce the rate of death or hospitalization in patients with chronic heart failure?
P
Population
Patients with chronic heart failure
I
Intervention
Etanercept (targeted anticytokine therapy)
O
Outcome
Rate of death or hospitalization due to chronic heart failurecomposite
Etanercept does not provide a clinically relevant benefit for reducing death or hospitalization in patients with chronic heart failure.
Abstract
The results of RENEWAL rule out a clinically relevant benefit of etanercept on the rate of death or hospitalization due to chronic heart failure.